Globe News Wire
01 Dec 2025, 22:42 UTC · 41w ago
Verdict
Headline takes no side. We score DOW −1.00 across five claims — strongly bearish.
−1.00strongly bearish
More negative than 96% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
Atkore Inc. (ATKR) is facing allegations of participating in an anticompetitive price-fixing scheme for PVC pipe products to artificially inflate financial results.
More negative than 96% of claims this week
Alto Neuroscience (ANRO) is alleged to have misrepresented the efficacy and commercial prospects of its major depressive disorder drug candidate, ALTO-100.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 92% of claims this week
Dow Inc. (DOW) is facing a class action alleging it misled investors regarding dividend sustainability and its ability to manage macroeconomic pressures.
More negative than 86% of claims this week
Fly-E Group, Inc. (FLYE) is alleged to have downplayed safety issues and regulatory problems related to its lithium-battery technology.
More negative than 86% of claims this week
Law firm Johnson Fistel, PLLP is investigating breaches of fiduciary duty and seeking corporate governance reforms for shareholders of ANRO, ATKR, DOW, and FLYE.
More negative than 67% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a securities class action lawsuit alleging it misled investors regarding dividend sustainability and macroeconomic pressures.
More negative than 96% of ticker scores this week
The company is facing a securities class action lawsuit alleging misleading statements regarding drug efficacy and financial outlook.
More negative than 96% of ticker scores this week
The company is facing a securities class action lawsuit alleging participation in an anticompetitive price-fixing scheme.
More negative than 96% of ticker scores this week
The company is facing a class action lawsuit alleging it misrepresented safety issues related to its lithium-battery technology.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+24.4%
Price is moving against the score
$29.66 vs $23.84 close before publication (Dec 1) · not market-adjusted
DOW chart →
